Bakkt Holdings, Inc. Form 8-K Summary
Business context and reporting period
Bakkt Holdings, Inc. filed a Current Report on Form 8-K dated October 12, 2022, with the report signed on October 13, 2022. The filing concerns the appointment and compensation arrangements of Karen Alexander, the Company’s Chief Financial Officer and Principal Financial Officer. It is not a quarterly or annual financial results filing.
Financial metrics and liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating or financial performance metrics.
Material changes versus the prior comparable period
- On October 12, 2022, the Company entered into a new Employment Agreement with Ms. Alexander.
- The agreement replaces and supersedes her prior agreements with the Company.
- Ms. Alexander’s annual base salary is $400,000, with an annual target bonus equal to 100% of base salary.
- The agreement includes terms for an initial equity grant, eligibility for future discretionary equity awards, employee benefits, and vacation accrual.
Outlook, contingencies, and unusual items
- The agreement has an initial one-year term and automatically renews for successive one-year periods unless either party provides notice of non-renewal.
- Upon certain qualifying terminations unrelated to a change in control, Ms. Alexander may receive two times base salary, a bonus-based payment, accelerated vesting of certain equity awards, a one-year post-termination option exercise period, and one year of COBRA premiums.
- Upon certain qualifying terminations within two years following a change in control, the severance terms are generally similar, but the bonus calculation uses the greatest of specified historical bonus measures and performance-based equity vesting is based on the greater of target or actual performance through the change in control.
- Severance is conditioned on execution of a release of claims agreement.
- The agreement includes confidentiality obligations and one-year post-termination non-solicitation and non-competition covenants.
- The initial equity grant terms are described in the Company’s Form 8-K/A filed October 13, 2022, which is incorporated by reference.
Key facts for investors to verify
- Review Exhibit 10.1 for the complete employment, severance, change-in-control, restrictive covenant, and equity-award provisions.
- Review the October 13, 2022 Form 8-K/A for the terms and potential dilution associated with the initial equity grant.
- Assess the potential future compensation expense and equity dilution from salary, bonuses, equity awards, accelerated vesting, and severance obligations.
- Confirm whether any termination, change-in-control, or non-renewal events have occurred since the filing date.